INTERNATIONAL ANESTHESIA RESEARCH SOCIETY
Balance Sheet
Fiscal Year: 2024
Assets in 2024 (Year End)
$35,300,984
Investments
88%
Cash & Equivalents
11%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Receivables (Non-Related)
<1%
Related-Party Receivables
0%
Inventories
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$6,758,076
Deferred Revenue
64%
Notes Payable / Debt (Non-Related)
13%
Payables & Accruals
11%
Grants Payable
11%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$342,235
$4,016,787
+1074%
Receivables (Non-Related)
$245,443
$2,240
-99%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$108,649
$91,634
-16%
Investments
$28,932,921
$31,185,835
+8%
Property, Plant, & Equipment (net)
$31,415
$4,488
-86%
Other Assets
-
-
-
Total Assets
$29,660,663
$35,300,984
+19%
Liabilities
2023
2024
Change
Payables & Accruals
$1,733,993
$772,933
-55%
Grants Payable
$930,876
$768,710
-17%
Deferred Revenue
$475,019
$4,316,433
+809%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$850,000
$900,000
+6%
Related-Party Payables
-
-
-
Other Liabilities
$0
-
-
Total Liabilities
$3,989,888
$6,758,076
+69%
Net assets
2023
2024
Change
Restricted Net Assets
$48,209
$0
-100%
Unrestricted Net Assets
$25,622,566
$28,542,908
+11%
Net assets
2023
2024
Change
Net assets
+$25,670,775
+$28,542,908
+11%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)